Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
life sciences
national blog main
new york blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
clinical trials
detroit blog main
detroit top stories
drugs
gene editing
indiana blog main
indiana top stories
johnson & johnson
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
ac immune
achaogen
acquisition
adams street partners
alector
alkermes
What
biopharma
3
×
bio
roundup
bacteria
business
car
celgene
colleagues
company
congress
congressional
crispr
disease
drug
executives
exited
exome
feud
fighting
government
group
health
hundreds
industry
infections
infectious
isn’t
known
later
launches
medicine
medicines
melinta
month
new
ny
pharma
policy
products
published
Language
Current search:
biopharma
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections